Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women

This study has been completed.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by:
University of KwaZulu
ClinicalTrials.gov Identifier:
NCT00343317
First received: June 21, 2006
Last updated: NA
Last verified: May 2005
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: May 2005
  Estimated Primary Completion Date: No date given